BioFlo Ports with Endexo TechnologyProven to Minimize Thrombus Accumulation1
The BioFlo* Port is the first implantable port with Endexo* Technology, providing a catheter material more resistant to the accumulation of blood components (platelets and thrombus).1
Make protection part of the mix.
Endexo Technology is a permanent and non-eluting polymer that is “blended” into the polyurethane from which the catheter is made. It is present throughout the catheter including the extraluminal, intraluminal and cut catheter surface of the tip. Endexo Technology remains present for the life of the catheter and provides a catheter material more resistant to thrombus accumulation.1
- CT-rated up to 5mL/sec and 300 psi and MRI-conditional—3 Tesla.
- Radiopaque under fluoroscopy
- Flexible, kink-resistant catheter material
- 1/2” septum diameter for ease of port access
Available with PASV Valve Technology, designed to resist backflow, maintain long-term patency, and provide a saline-only flushing option.
Easily Identify Critical Information
- Radiopaque “CT” lettering confirms if port is power injectable or flipped
- Patient reminder band, ID card, key tag and record sticker provide added verification that the port is power injectable
1The reduction in thrombus accumulation was evaluated using in-vitro and in-vivo models. Pre-clinical in-vitro and in-vivo evaluations do not necessarily predict clinical performance with respect to thrombus formation.
2Based on benchtop test results which may not be indicative of clinical results. Data on file.
3Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA. A Prospective Randomized Trial Demonstrating Valved Implantable Ports Have Fewer Complications and Lower Overall Cost than Non-valved Implantable Ports. Am J Surg 2004;188:722-727. (Clnical data based on Vaxcel with PASV port.)
4Failure to achieve blood draw: non-valved=$480, valved=$303; $177 net savings per port. General maintenance costs: non-valved=$195, valved=$109; $86 net savings per port. Cost information based on data from 2004.